Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases

Published: Thursday, February 13, 2014
Last Updated: Thursday, February 13, 2014
Bookmark and Share
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Flex Databases has announced that Global Clinical Trials, LLC (GCT) has selected Flex CRO Starter Kit™ as its business automation platform.

GCT is a regional Contract Research Organization (CRO), established in 2001 and headquartered in Princeton, NJ with full-service clinical operations in Russia and Eastern Europe.

"From the very foundation of the company GCT had a clear growth strategy", says Dr. Eugene Selivra, CEO of GCT. "We developed organically, step by step, basing our growth on the experience and knowledge of the management team and efficient business processes. But we always knew a time would come when we would need a software platform to help us handle the increased complexity, size and number of projects. We explored the market in search of a system that would become a core application, driving all of our day-to-day activities. The CRO Starter Kit™ platform became a perfect match for our needs. It has vital tools for a CRO today, such as budget management, eTMF, a Learning Management System, timesheets and more. But above all, CRO Starter Kit™ is a unique platform where ground level operational activities are seamlessly linked to project management, providing increased efficiency and speed in running clinical research projects."

"CRO Starter Kit™ is a platform which brings the company together, creating an environment where every action is interconnected with others", says Timur Galimov, Technical Director of Flex Databases. "Such a system becomes self-reinforcing and is much easier to adopt, because it touches a user from multiple angles. One of the big reasons why CTMS implementations fail is because they affect a limited number of users and become just another database, not connected to anything else and not affecting anything else. The experience and industry knowledge of GCT allowed them to avoid this pitfall by selecting Flex CRO Starter Kit™."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!